Quote
—
—
No scored catalysts in the window yet.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
https://www.accessnewswire.com/newsroom/en/biotechnology/microbix-reports-results-for-q3-fiscal-2026-1206908 · 8/13/2026+0.30
https://www.globenewswire.com/news-release/2026/07/13/3326463/0/en/MBX-Biosciences-Announces-Executive-Leadership-Transition-to-Support-the-Company-s-Next-Phase-of-Growth.html · 7/13/2026+0.00
https://www.fool.com/coverage/etfs/2026/07/08/which-healthcare-etf-is-the-better-buy-invesco-s-ibbq-or-state-street-s-xph/ · 7/8/2026-0.30
https://seekingalpha.com/article/4914571-mbx-biosciences-inc-mbx-discusses-one-year-data-from-phase-ii-open-label-extension-study-of · 6/12/2026+0.60
https://www.defenseworld.net/2026/04/04/critical-analysis-immune-therapeutics-otcmktsimun-mbx-biosciences-nasdaqmbx.html · 4/4/2026
https://www.globenewswire.com/news-release/2026/04/03/3267994/0/en/MBX-Biosciences-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html · 4/3/2026+0.20
https://www.globenewswire.com/news-release/2026/03/09/3251975/0/en/CORRECTING-REPLACING-MBX-Biosciences-Announces-Successful-End-of-Phase-2-FDA-Meeting-and-Provides-Phase-3-Development-Plan-for-Once-Weekly-Canvuparatide-for-Hypoparathyroidism.html · 3/9/2026+0.80
https://www.defenseworld.net/2026/02/15/microbix-biosystems-q1-earnings-call-highlights.html · 2/15/2026+0.40
https://www.defenseworld.net/2026/01/10/microbix-biosystems-tsembx-shares-cross-below-50-day-moving-average-should-you-sell.html · 1/10/2026-0.20
https://www.defenseworld.net/2025/12/25/mbx-biosciences-nasdaqmbx-reaches-new-12-month-high-still-a-buy.html · 12/25/2025+0.80
https://www.globenewswire.com/news-release/2025/12/15/3205354/0/en/MBX-Biosciences-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference-on-January-13.html · 12/15/2025+0.20
https://www.fool.com/coverage/filings/2025/11/27/biotech-fund-reveals-usd15-million-moonlake-exit-after-stock-s-90-crash/ · 11/27/2025-0.30
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
